Skip to main content

Day: June 2, 2020

WILDFLOWER REPORTS REVENUES OF $5.3 MILLION

VANCOUVER, British Columbia, June 02, 2020 (GLOBE NEWSWIRE) — via NetworkWire – Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF) (the “Company”) announces $5.3M in revenues in its third quarter, compared to $2.5M in the previous year’s third quarter and $5.5M in the second quarter. Revenues were slightly less than last quarter even though business was affected by Covid-19. Even with these unforeseen circumstances Wildflower was able to operate with a net gain of $101,435 compared to a loss of $(1,019,862) Q3 2019.Highlights for the quarter ending March 31, 2020 (with comparisons to the prior year’s quarter except as otherwise noted) include the following:Revenues of $5,301,762 (Q3 2019: $2,547,230), including sales in British Columbia’s provincially regulated cannabis market, US nationwide e-commerce sales, nationwide US wholesale...

Continue reading

Standard Uranium Ltd. Announces C$3,000,000 Public Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/VANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) — Standard Uranium Ltd. (“Standard Uranium” or the “Company”) (TSX-V: STND) is pleased to announce that it has entered into a letter agreement (the “Agreement”) with Red Cloud Securities Inc. (“Red Cloud”) as lead agent on behalf of a syndicate of agents (collectively, the “Agents”) and has filed and obtained a receipt for a preliminary short form prospectus (the “Preliminary Prospectus”) with the securities regulators in each of the Provinces of Canada other than the Province of Québec, pursuant to which the Company proposes to complete a public offering (the “Offering”) of units for gross proceeds of C$3,000,000 (the “Offered Securities”). Closing of the Offering is expected...

Continue reading

Saturn Oil & Gas Inc. Postpones release of First Quarter 2020 Results

CALGARY, Alberta, June 01, 2020 (GLOBE NEWSWIRE) — Saturn Oil & Gas Inc. (“Saturn” or the “Company”) (TSX.V: SOIL) (FSE: SMK) announced today that due to the impact of the global COVID-19 pandemic, it will postpone the filing of its interim financial statements (“Financial Statements”) and management’s discussion and analysis (“MD&A”) for the first quarter period ended March 31, 2020, until no later than June 8, 2020.The Company will be relying on the exemption provided in BC Instrument 51-515 Temporary Exemption from Certain Corporate Finance Requirements (and similar exemptions provided by other Canadian securities regulators).Until the Company has filed its Financial Statements and MD&A, members of the Company’s Board, management and other insiders are subject to an insider trading...

Continue reading

Fortress Technologies Inc. Announces First Quarter 2020 and Year End 2019 Financial Results

VANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) — Fortress Technologies Inc. (“Fortress” or the “Company”) (TSXV: FORT), a well-capitalized company currently evaluating emerging opportunities in technology sectors, reports its results of operations for the first quarter and three month period ended March 31, 2020 (“Q1 2020”) and for the fourth quarter and full year ended December 31, 2019 (“YE 2019”). For the full condensed consolidated interim financial statements and management discussion & analysis for the Q1 2020 and YE 2019, please visit the Company’s profile on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com. Three-Months Ended March 31, 2020“We are pleased to report a net income of $640,263 for the first quarter of 2020, which results in an earnings per share of $0.01...

Continue reading

Guardant Health Announces Pricing of Upsized Public Offering

REDWOOD CITY, Calif., June 01, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today announced the pricing of an underwritten public offering of 11,500,000 shares of its common stock at a public offering price of $84.00 per share, before deducting underwriting discounts and commissions (3,750,000 of which are being sold by Guardant Health and 7,750,000 are being sold by SoftBank Investment Advisers). The public offering was increased from the previously announced offering size of 10,000,000 shares of common stock. In addition, Guardant Health and SoftBank Investment Advisers have granted the underwriter a 30-day option to purchase up to...

Continue reading

Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares

PHILADELPHIA and OXFORDSHIRE, United Kingdom, June 01, 2020 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (“Adaptimmune”)(Nasdaq: ADAP), a leader in cell therapy to treat cancer, today announced the pricing of an underwritten public offering of 20,500,000 of its American Depositary Shares (“ADSs”) at a price to the public of $11.00 per ADS. In connection with the offering, Adaptimmune has granted the underwriters a 30-day option to purchase up to an additional 3,075,000 ADSs at the public offering price. The gross offering size for this offering is expected to be $225.5 million, excluding any exercise of the underwriters’ option to purchase additional ADSs. All ADSs in this offering are being sold by Adaptimmune with net proceeds to be used to advance the development of Adaptimmune’s immunotherapies into and through clinical trials...

Continue reading

WSP Announces a $437 Million Public Offering of Common Shares and a Concurrent $64 Million Private Placement From CDPQ and CPP Investments

MONTREAL, June 01, 2020 (GLOBE NEWSWIRE) — WSP Global Inc. (TSX:WSP) (“WSP” or the “Corporation”) is pleased to announce that it has entered into an agreement with CIBC Capital Markets, National Bank Financial Inc. and TD Securities Inc. acting as joint bookrunners, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Corporation will issue from treasury, and the Underwriters shall purchase on a “bought deal” basis, 5,080,000 common shares (the “Shares”) at a price of $86.00 per Share (the “Offer Price”) for gross proceeds to the Corporation of approximately $437 million (the “Offering”).In addition, WSP has entered into agreements under which the Corporation will complete a private placement of common shares at the Offer Price with Caisse de dépôt et placement du Québec (“CDPQ”), for...

Continue reading

WSP annonce un placement public d’actions ordinaires de 437 millions de dollars et un placement privé simultané de 64 millions de dollars avec la Caisse et Investissements RPC

MONTRÉAL, 01 juin 2020 (GLOBE NEWSWIRE) — Groupe WSP Global Inc. (TSX :WSP) (« WSP » ou la « Société ») est heureuse d’annoncer la conclusion d’une entente avec Marchés des capitaux CIBC, Financière Banque Nationale inc. et Valeurs Mobilières TD Inc., en qualité de coteneurs de livres, pour le compte d’un syndicat de preneurs fermes (collectivement, les « preneurs fermes »), aux termes de laquelle la Société émettra et les preneurs fermes s’engagent à souscrire 5 080 000 nouvelles actions ordinaires (les « actions ») au prix de 86.00 $ l’action (le « prix d’offre »), ce qui rapportera à la Société un produit brut d’environ 437 millions de dollars (le « placement »).De plus, WSP a conclu des conventions aux termes desquelles la Société réalisera un placement privé d’actions ordinaires au prix d’offre avec la Caisse de dépôt et placement...

Continue reading

Kaleido Biosciences Announces Pricing of Public Offering of Common Stock

LEXINGTON, Mass., June 01, 2020 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced the pricing of an underwritten public offering of 4,750,000 shares of its common stock at a public offering price of $7.50 per share. In addition, Kaleido has granted the underwriters a 30-day option to purchase up to an additional 712,500 shares of its common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds to Kaleido from this offering are expected to be approximately $35.6 million, before deducting underwriting discounts and commissions and other estimated offering expenses and excluding any exercise of the underwriters’ option to...

Continue reading

Retail Opportunity Investments Corp. Provides Portfolio Update

SAN DIEGO, June 01, 2020 (GLOBE NEWSWIRE) — Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today the following portfolio and operating statistics as of May 29, 2020:All 88 shopping centers are open and operating98% of total portfolio (86 shopping centers) are grocery and/or drug-store anchored76.5% of total tenants are open and operating (based on annualized base rent)71.0% of May 2020 billed monthly base rent has been paid to dateStuart A. Tanz, President and Chief Executive Officer of Retail Opportunity Investments Corp. stated, “Given that our tenant base is predominately comprised of essential businesses, providing daily-necessity goods and services to their communities, our portfolio continues to perform remarkably well during the COVID-19 pandemic, with our portfolio’s May performance being consistent with April. ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.